Dong Zhao serves as the Senior Director and Head of China and the APAC Region for Global Regulatory Operations (GRO) Submissions Management at Pfizer, where he plays a pivotal role in navigating the complex landscape of regulatory submissions across diverse markets. With a robust background...
Dong Zhao serves as the Senior Director and Head of China and the APAC Region for Global Regulatory Operations (GRO) Submissions Management at Pfizer, where he plays a pivotal role in navigating the complex landscape of regulatory submissions across diverse markets. With a robust background in the bio-pharmaceutical industry, Dong brings extensive expertise in biotechnology, development operations, and global regulatory frameworks. His leadership is instrumental in overseeing a dedicated team of regional submission managers who are responsible for ensuring the timely and compliant registration of innovative therapies in China and other APAC countries.
Under Dong's guidance, the team focuses on optimizing regulatory submission processes, leveraging his strengths in continuous improvement and project management. He is adept at fostering collaboration among cross-functional teams to streamline workflows, enhance efficiency, and drive successful outcomes in drug registration. His proficiency in regulatory submissions, combined with a deep understanding of molecular biology and recombinant DNA technology, enables him to navigate the intricate regulatory requirements that vary across the APAC region.
Dong's commitment to excellence is evident in his approach to change management and process design, where he emphasizes the importance of adaptability in an ever-evolving industry. He is also passionate about mentoring and developing talent within his team, ensuring that they are equipped with the necessary skills to excel in a competitive landscape. Through his strategic vision and operational acumen, Dong Zhao is not only advancing Pfizer's mission to deliver life-changing therapies but also contributing to the broader goal of enhancing public health across the Asia-Pacific region.
